Haisco Pharmaceutical Hits Day High with Strong 3.79% Intraday Surge

Haisco Pharmaceutical Group Co., Ltd. has experienced a notable increase of 3.79% on March 17, 2026, reaching an intraday high of CNY 51.70. This performance stands in contrast to the broader market, as the China Shanghai Composite index declined by 0.85% on the same day. Over the past week, Haisco has shown a positive trend with a 2.46% gain, while the one-month performance reflects a robust increase of 5.75%. Year-to-date, however, the stock has seen a slight decline of 1.17%. In terms of longer-term performance, Haisco has delivered impressive returns, with a 45.87% increase over the past year and a remarkable 114.92% rise over the last three years. Despite these gains, the company faces challenges with a relatively high price-to-earnings ratio of 141.00 and a return on equity of 7.32%. The market capitalization stands at CNY 25,698 million, classifying it as a large-cap entity within the pharmaceuticals and biotechnology sector. Haisco's dividend yield is currently at 0.59%, indicating a commitment to returning value to shareholders.